Page last updated: 2024-08-24

arctigenin and cyclin d1

arctigenin has been researched along with cyclin d1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Liu, C; Luo, L; Yao, X; Yin, Z; Zhao, Z; Zhu, F1
Feng, S; Li, X; Liu, Y; Lv, X; Ma, J; Xiao, J; Yang, H; Yang, S; Zhang, Y1
Li, A; Wang, J; Wu, M; Zhang, H; Zhang, X1
Liu, XP; Shao, TL; Shen, XB; Wang, GD; Yuan, PC; Zhu, L1
Lee, KS; Lee, MG; Nam, KS1

Other Studies

5 other study(ies) available for arctigenin and cyclin d1

ArticleYear
Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Journal of cellular biochemistry, 2011, Volume: 112, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Blotting, Western; Cell Line, Tumor; Cisplatin; Cyclin D1; Flow Cytometry; Furans; G1 Phase; HeLa Cells; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Janus Kinase 1; Janus Kinase 2; Lignans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Signal Transduction; STAT3 Transcription Factor; Ubiquitin-Protein Ligases

2011
Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis.
    Anatomical record (Hoboken, N.J. : 2007), 2012, Volume: 295, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Flow Cytometry; Furans; Humans; Lignans; Mitogen-Activated Protein Kinases; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2012
The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    European journal of pharmacology, 2015, Jan-15, Volume: 747

    Topics: 14-3-3 Proteins; Active Transport, Cell Nucleus; Becaplermin; Cell Line; Cell Nucleus; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Forkhead Box Protein O3; Forkhead Transcription Factors; Furans; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Hepatic Stellate Cells; Humans; Lignans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Resting Phase, Cell Cycle; RNA, Small Interfering; Signal Transduction

2015
Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation.
    Life sciences, 2020, Sep-01, Volume: 256

    Topics: Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Female; Furans; Glycogen Synthase Kinase 3; Humans; Lignans; MCF-7 Cells; Proteolysis; Receptors, Estrogen

2020
Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
    IUBMB life, 2023, Volume: 75, Issue:9

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Necrosis

2023